FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
JUNE 2016

POSSESSION USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
NEPHROLOGY
PAPER II
NEPH/J/16/20/II
Time 3 hours
Max. Marks 100
Important instructions:
• Attempt all questions in order.
• Each question carries 10 marks.
• Read the question carefully and answer to the point neatly and legibly.
• Do not leave any blank pages between two answers.
• Indicate the question number correctly for the answer in the margin space.
• Answer all the parts of a single question together.
• Start the answer to a question on a fresh page or leave adequate space between two answers.
• Draw table/diagrams/flowcharts wherever appropriate.
Write short notes on:
1. Histological variants of focal segmental glomerulosclerosis
(FSGS).
Risk factors for progression of renal disease in FSGS.
Therapeutic options in FSGS.

2. IgA Nephropathy: Pathogenesis, Oxford classification and treatment
recommendation.

3. Small vessel pauci immune vasculitis under the following heads:-
Clinico pathological variants of pauci immune vasculitis
Antineutrophil cytoplasmic autoantibodies.
Management of pauci immune vasculitis

4. Monoclonal Gammopathy of renal significance under the following
heads:
Diagnostic criteria
Classification of renal disease by deposits
Treatment

5. ADAMTS 13 TTP.
Renal disease associated with rheumatoid arthritis.
ISN/RPS classification of lupus nephritis.

6. Hypertension in pregnancy under the following heads:-
Definition classification of hypertensive disorders.
Physiological changes in pre-eclampsia.
Management

P.T.O.
FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
JUNE 2016

POSSESSION USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
NEPHROLOGY
PAPER II
7. Management of urinary tract infection under the following heads:-
Asymptomatic bacteriuria in renal transplants.
Emphysematous pyelonephritis.
5+5
8. Mention the kidney diseases associated with human
immunodeficiency virus infection.
Acceptability criteria of HIV positive ESRD for renal transplant.
Immunosuppressive protocols in HIV positive renal transplant
recipients.

9. Hepatitis C virus infection in ESRD on Haemodialysis under the
following heads:-
Clinical presentation
Diagnosis of HCV infection pit falls.
Direct acting anti-viral medication.

10. 'International Reflux Study in children' Classification of vesico
ureteric reflux (VUR).
Clinical presentation of VUR.
Imaging tools in diagnosis of VUR.
Medical Vs surgical management of VUR.